Lululemon (LULU) shares are experiencing a significant sell-off, trading near COVID-era lows, despite Q2 revenue growth and bottom-line outperformance, due to reported weakness in its U.S. segment and a substantial reduction in Q3 and full-year guidance. The company now projects roughly 5% comparable growth and anticipates a 1200 basis point earnings impact from tariffs and shipping changes, leading to a deteriorating analyst consensus price target and increased institutional selling and short interest. This convergence of factors suggests further downside potential for LULU as the market re-prices the stock for a challenging outlook, with technical indicators pointing to potential targets significantly below current levels.
Lululemon (LULU) has experienced a significant valuation reset, with its stock declining 18.58% to near its COVID-era support level around $165. This sell-off was not triggered by poor Q2 results, which saw 6.8% revenue growth and a bottom-line beat, but rather by a material reduction in forward guidance. The company cited weakness in its U.S. segment and now projects only 5% comparable growth for the full year, below consensus. More critically, the earnings outlook has been substantially impaired by an anticipated 1200 basis point impact from tariffs and the end of de minimis shipping. This negative outlook has galvanized bearish sentiment across key market participants. The analyst consensus price target has fallen over 40% in the last year, and institutional investors, who own 85% of the stock, have shifted from net buyers to net sellers in Q3. Concurrently, short interest, at 6.7% pre-release, is expected to increase, adding further pressure. Technical analysis supports a continued downtrend, with the breakdown of long-term support suggesting a potential move towards $135 or lower.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.70
Ticker Sentiment